Breaking News Instant updates and real-time market news.

AAPL

Apple

$183.83

6.93 (3.92%)

, AXP

American Express

$98.37

1.22 (1.26%)

14:19
05/05/18
05/05
14:19
05/05/18
14:19

Buffett's Berkshire boosted Apple stake to $40.7B in Q1

Warren Buffett's Berkshire Hathaway (BRK.A, BRK.B) disclosed this morning that its stake in Apple rose to $40.7B as of March 31, 2018, or the end of Q1. Approximately 68% of Berkshire's $172.98B aggregate fair value was concentrated in five companies: American Express (AXP) at $14.1B; Apple at $40.7B; Bank of America (BAC) at $21B; Coca-Cola (KO) at $17.4B and Wells Fargo (WFC) at $25.2B. At December 31, 2017, Berkshire's stake in Apple was $28.2B.

AAPL

Apple

$183.83

6.93 (3.92%)

AXP

American Express

$98.37

1.22 (1.26%)

KO

Coca-Cola

$42.36

0.475 (1.13%)

WFC

Wells Fargo

$52.40

0.85 (1.65%)

BAC

Bank of America

$29.31

0.11 (0.38%)

BRK.A

Berkshire Hathaway

$293,240.00

6080 (2.12%)

BRK.B

Berkshire Hathaway

$195.83

4.32 (2.26%)

  • 05

    May

  • 05

    May

  • 07

    May

  • 07

    May

  • 10

    May

  • 10

    May

  • 17

    May

  • 17

    May

  • 30

    May

AAPL Apple
$183.83

6.93 (3.92%)

05/02/18
OPCO
05/02/18
NO CHANGE
OPCO
Perform
Oppenheimer remains skeptical over Apple's ability to maintain market dominance
Oppenheimer analyst Andrew Uerkwitz believes the June quarter guidance and major share repurchase plan should ease some concerns for a negative surprise in the near-term. However, the analyst remains skeptical over Apple's ability to maintain its market dominance in the mid- to-long term when competitors in software and services erode its hardware differentiation. Uerkwitz reiterates a Perform rating on the shares.
05/02/18
BARD
05/02/18
NO CHANGE
Target $200
BARD
Outperform
Apple platform remains strong, says Baird
Baird analyst William Power said Apple reported solid Q2 results and noted they were driven by significant services revenue upside and strong China growth. He also noted guidance was better than feared, allying concerns of a more severe sequential decline. He said with iPhone results solid, and services surging, he believes the Apple platform remains strong. Power reiterated his Outperform rating and $200 price target on Apple shares.
05/04/18
OPCO
05/04/18
NO CHANGE
Target $120
OPCO
Outperform
Oppenheimer remains a buyer of Skyworks following Q2 results
Oppenheimer analyst Rick Schafer said he remains a buyer of Skyworks (SKWS) following the company's Q2 earnings. In a research note to investors, Schafer noted that while the June quarter outlook why shy of consensus expectations, it was likely better than feared given recent Apple (AAPL)-related foodchain cuts, adding that he believes weaker iPhone units were likely aggravated by a ramp down at Samsung (SSNLF) following an above-seasonal GS9 ramp in the first calendar quarter of the year. The analyst has an Outperform rating and $120 price target on shares.
05/04/18
CHLM
05/04/18
NO CHANGE
Target $115
CHLM
Buy
Skyworks price target lowered to $115 from $125 at Craig-Hallum
Craig-Hallum analyst Tony Stoss lowered his price target on Skyworks (SWKS) to $115 from $125M and reiterated a Buy rating on shares after the company reported Q2 quarter results that were above expectations. In a research note to investors, Stoss noted that weaker iPhone sales in the quarter were slightly offset by both strong sales as well as content gains in the S9, and that June quarter guidance was "better than feared" but weaker than expectations as continued Apple (AAPL) weakness and the removal of ZTE-related revenues impacted the quarter. Additionally, Stoss said that Huawei is "a risk" in the near-term given the scrutiny it faces in the U.S. for similar-to-ZTE business practices.
AXP American Express
$98.37

1.22 (1.26%)

04/20/18
LOOP
04/20/18
NO CHANGE
Target $34
LOOP
Buy
Syntel 'out of the woods' after tough 2017, says Loop Capital
Loop Capital analyst Joseph Vafi raised his price target on Syntel (SYNT) to $34 from $32 and kept his Buy rating following Q1 results that were well ahead of consensus. Vafi says that after a year and a half of top-line contraction, the company finally grew sales, with "solid" performance driven by traction in clients and decelerating headwinds from key client American Express (AXP). The analyst adds that margins were strong, even though there is some concern about "overspending on skill sets".
04/19/18
BERN
04/19/18
NO CHANGE
Target $120
BERN
Outperform
American Express price target raised to $120 from $115 at Bernstein
Bernstein analyst Kevin St. Pierre raised his price target for American Express to $120 from $115 after a "strong" quarter. The analyst reiterates an Outperform rating on the shares.
04/19/18
JMPS
04/19/18
NO CHANGE
JMPS
Market Perform
AmEx Q1 EPS appears to be high-water mark for year, says JMP Securities
After American Express reported Q1 EPS that topped the consensus forecast, JMP Securities analyst David Scharf noted that American Express' average quarterly EPS for the remainder of the year is slightly below the Q1 level, even at the high end of management's 2018 guidance. He raised his 2018 EPS estimate to account for the flow-through of Q1 upside and also raised his 2019 estimate based on the increasing momentum in customer engagement. However, he keeps a Market Perform rating on American Express shares, which he views as fairly valued at current levels.
04/19/18
RBCM
04/19/18
NO CHANGE
Target $86
RBCM
Underperform
American Express price target raised to $86 from $81 at RBC Capital
RBC Capital analyst Jason Arnold raised his price target on American Express to $86 after the company beat on Q1 earnings beat and updated its FY18 outlook to the upper end of its prior guidance. Despite the stronger results however, the analyst remains concerned with the heightened competition, uncertainty around the pending Department of Justice lawsuit, and relative returns. Arnold keeps his Underperform rating on American Express, saying the upside/downside risk on shares is "less exciting".
KO Coca-Cola
$42.36

0.475 (1.13%)

04/17/18
GSCO
04/17/18
UPGRADE
Target $46
GSCO
Neutral
Coca-Cola upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Judy Hong upgraded Coca-Cola (KO) to Neutral while reducing her price target for the shares to $46 from $47. The analyst coupled the upgrade with a downgrade of PepsiCo (PEP) to Sell. For Coca-Cola, the analyst sees an improving organic sales growth outlook, "cleaner base" post-refranchising, and better visibility on its margin and earnings targets. She calls the company "one of the rare" over 4% organic growth mega-cap stories in Americas Beverages.
04/17/18
GSCO
04/17/18
DOWNGRADE
Target $110
GSCO
Sell
PepsiCo downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Judy Hong downgraded PepsiCo (PEP) to Sell and lowered her price target for the shares to $110 from $118. The potential for continued softer North American Beverage volumes could weigh on the company's organic sales growth, Hong tells investors in a research note. She believes PepsiCo's organic growth underperformance relative to Coca-Cola (KO) could widen. Further, Coca-Cola's current price-to-earnings premium versus PepsiCo of 10% could widen to 15%, the analyst contends.
03/14/18
RBCM
03/14/18
NO CHANGE
Target $56
RBCM
Outperform
Coca-Cola can achieve its revenue growth target, says RBC Capital
RBC Capital analyst Nik Modi keeps his Outperform rating and $56 price target on Coca-Cola - his "top mega cap pick" - despite the poor investor sentiment on the stock driven by "rising rates, ETF outflows, and sector rotation". Modi believes that the slowdown in volume growth from 2013 was driven by specific issues around the company's bottler partners and decelerating macro environment, however the more recent data from global bottlers suggest "accelerating share gains, improving emerging market macros, improving local level execution, and more effective marketplace investment". The analyst adds that despite the stock outperforming relative to other staples, it can gain as much as 40% more over the next two years.
04/17/18
04/17/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Hold from Sell at Pivotal Research with analyst Brian Wieser saying the company "has a lot of positive elements" heading into the back half of the year, including a strong film slate, the launch of new direct to consumer over-the-top services, and efforts in support of the close of the Fox (FOXA) transaction. 2. Coca-Cola (KO) upgraded to Neutral from Sell at Goldman Sachs with analyst Judy Hong saying she sees an improving organic sales growth outlook, "cleaner base" post-refranchising, and better visibility on its margin and earnings targets. 3. Merck (MRK) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying the Keytruda+chemo combination showed better than expected results in lung cancer, boosting the company's immuno-oncology lead against Bristol-Myers (BMY). 4. Newell Brands (NWL) upgraded to Outperform from Market Perform at Wells Fargo with analyst Bonnie Herzog saying the stock's setup is good looking forward, with greater potential upside than downside risk over the next 12 months. 5. Twitter (TWTR) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Brian Nowak citing recent advertiser conversations that have continued to be incrementally positive about Twitter's ad business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
WFC Wells Fargo
$52.40

0.85 (1.65%)

04/17/18
BMOC
04/17/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America is the best of the 'big four' U.S. banks, says BMO Capital
BMO Capital analyst James Fotheringham kept his Market Perform rating and $34 price target on Bank of America (BAC) after its in-line Q1 earnings but raised his FY18 EPS view to $2.62 from $2.59 and FY19 view to $3.18 from $3.12. Fotheringham says than in contrast, he lowered earnings forecasts for JPMorgan (JPM), Wells Fargo (WFC), and Citigroup (C) because of higher costs and lower revenues, but Bank of America's better than expected net interest income rise justifies his view of the bank as the "best of the bunch". The analyst also notes the bank's more favorable valuation trading at a below-average two-year-forward P/E multiple despite his forecast of double the core earnings growth rate of Bank of America's peers.
04/30/18
04/30/18
UPGRADE

Outperform
Wells Fargo double upgraded to Outperform at Macquarie
Macquarie analyst David Konrad upgraded Wells Fargo to Outperform from Underperform with a $61 price target citing attractive valuation, low expectations, and near-term catalysts. Konrad said valuation and consensus estimates have finally come down and said shares are trading at 11.3x his 2019 "stressed earnings" estimate, compared to super regionals trading at 12.3x. The analyst expects low expense guidance at the upcoming investor day and passing CCAR in June to serve as positive catalysts for shares.
04/16/18
BARD
04/16/18
NO CHANGE
Target $62
BARD
Outperform
Lower expectations limit Wells Fargo downside, says Baird
Baird analyst David George said Wells Fargo reported messy Q1 results, but lowered expectations should limit the downside in the shares. The analyst said core fees were weak, but expenses were in line as was loan growth. George maintained his Outperform rating and $62 price target on Wells Fargo shares.
04/16/18
NOMU
04/16/18
NO CHANGE
Target $68
NOMU
Buy
Wells Fargo earnings underwhelming, but not a value trap, says Nomura
Nomura Instinet analyst Bill Carcache lowered his price target for Wells Fargo to $68 from $72 saying Friday's earnings results were "underwhelming" as the company reported softer revenue growth. The analyst, however, continues to believe that shares of Wells Fargo are "not a value trap." Shareholders "able to weather the current storm" will be rewarded with 10% earnings growth, mid- to high-teens return on tangible equity, and a multiple rerating when the market regains confidence, Carcache tells investors in a research note. He keeps a Buy rating on the shares.
BAC Bank of America
$29.31

0.11 (0.38%)

01/31/18
DBAB
01/31/18
NO CHANGE
Target $15
DBAB
Sell
GE likely to be dropped from Dow 30 index, says Deutsche Bank
General Electric (GE) is likely to be dropped from the Dow Jones Industrial Average after being in the index of 30 companies for over 110 years as an original member since 1896, Deutsche Bank analyst John Inch tells investors in a research note. The chances that GE could be removed from the Dow are increasing as the company continues to face "substantial challenges," the analyst writes. These include "earnings and cash pressure, tough global power generation markets, aggressive downsizing, shrinking its portfolio, management shake-up and SEC investigations," Inch argues. He sees "headline risk" as the most significant risk factor if GE were to be dropped from the Dow, "potentially amplified by GE's high mix of retail investors." Inch notes that the last major Dow shakeup occurred in September 2003, when American Airlines (AAL), Bank of America (BAC) and Hewlett Packard (HPQ) were removed and Goldman Sachs (GS), Nike (NKE) and Verizon (VZ) were added. Inch has a Sell rating on General Electric with a $15 price target. The shares closed yesterday down 33c to $15.95.
04/03/18
BMOC
04/03/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America pullback provides a buying opportunity, says BMO Capital
BMO Capital analyst James Fotheringham says that the recent near-10% pullback in the Bank of America stock price provides investors with a buying opportunity. The analyst contends that the bank's stock trades much more closely in line with short term interest rates rather than the 10-year and believes that its net interest margins will prove to be "insensitive" to lower yields on the benchmark as well as higher LIBOR-OIS spreads. Fotheringham keeps his $34 price target and Market Perform rating on Bank of America, adding that its current two-year-forward P/E valuation multiple is close to its long-term historical average.
02/02/18
MSCO
02/02/18
NO CHANGE
MSCO
BofA, JPMorgan, Citi best positioned for tougher CCAR test, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck said she had expected an easier stress test from the Federal Reserve but that the 2018 CCAR test actually seems tougher than last year, given the more intense recessions and lower asset prices modeled in it. A tougher test makes her less optimistic on her strong payout growth expectations, said Graseck, who sees Bank of America (BAC), JPMorgan (JPM) and Citi (C) as best positioned to "weather the storm" and increase payouts given their resilient balance sheets and significant excess capital. She sees Goldman Sachs (GS), which recently cut buybacks, as at risk from a tougher test, which likely weighs on the bank's 2018 ask, Graseck added.
BRK.A Berkshire Hathaway
$293,240.00

6080 (2.12%)

04/02/18
KEYB
04/02/18
NO CHANGE
KEYB
Efforts to strengthen in-store healthcare offering positive for Walmart, says KeyBanc
KeyBanc analyst Edward Yruma notes that the push to provide consumer-driven and lower-cost healthcare continues its push into retail as The Wall Street Journal reports that Walmart (WMT) is in discussions to acquire or develop a closer partnership Humana (HUM). This is on the heels of Amazon's (AMZN) recent JV with Berkshire Hathaway (BRK.A; BRK.B) and JPMorgan (JPM) to provide healthcare for employees, he adds. The analyst views any efforts to strengthen the in-store healthcare offering as a positive for Walmart's stock.
03/27/18
JEFF
03/27/18
NO CHANGE
Target $36
JEFF
Hold
USG board would likely agree to $45-$52 per share offer, says Jefferies
After taking a closer look at comparable transactions, Jefferies analyst Philip Ng believes a USG (USG) takeout price the board would agree to likely is in the $45-$52 per share range. Saint Gobain is the only logical strategic buyer that could potentially counter with a competitive offer to Knauf's, Ng tells investors in a research note. The analyst thinks Berkshire (BRK.A) appears to be a willing seller. He keeps a Hold rating on USG with a $36 price target.
02/05/18
BERN
02/05/18
NO CHANGE
BERN
More pronounced risks to drug supply chain from Amazon coalition, says Bernstein
Bernstein analyst Lance Wilkes thinks the risks to the drug supply chain from Amazon (AMZN), JPMorgan (JPM) and Berkshire Hathaway (BRK.A; BRK.B) healthcare joint venture are much more pronounced than risks to traditional MCOs. The analyst thinks the coalition could acquire a transparency PBM, effectively creating an employer PBM Co-op.
04/03/18
SBSH
04/03/18
NO CHANGE
SBSH
Buy
No news from GE could be considered good news, says Citi
Outside of a potential investment from Warren Buffett's Berkshire Hathaway (BRK.A), "no news" could be viewed as "good news" for General Electric (GE), Citi analyst Andrew Kaplowitz tells investors in a research note. No significant new "issues" have emerged following the announcement of GE's insurance reserves funding plan, nor in the company's annual filing published in late February, Kaplowitz argues. He believes that the more time passes with no significant new issues emerging, the more investors can gain confidence that new management can fully focus on executing a turnaround. Further, he sees "at least three specific areas in which inflections over the coming year could serve as catalysts to changing the narrative:" improving cash generation, asset sale announcements, and potentially inflecting energy end markets. Kaplowitz keeps a Buy rating on shares of General Electric. The stock closed yesterday down 36c to $13.12.
BRK.B Berkshire Hathaway
$195.83

4.32 (2.26%)

04/17/18
RHCO
04/17/18
NO CHANGE
Target $44
RHCO
Hold
USG price target raised to $44 from $34 at SunTrust
SunTrust analyst Keith Hughes raised his price target on USG (USG) to $44, saying he expects Knauf to raise its offer price for the company above the latest $42 bid while also anticipating the deal to close. Hughes adds that the support for the deal from Berkshire Hathaway (BRK.B) "greatly increases the odds" that the deal is finalized. Hughes keeps his Hold rating on USG.
01/31/18
CHLM
01/31/18
NO CHANGE
CHLM
Amazon consortium could be longer-term health care disruptor, says Craig-Hallum
Craig-Hallum analyst Kevin Ellich says that Amazon (AMZN), Berkshire Hathaway (BRK.A; BRK.B), and JPMorgan (JPM) new company focused initially on technology solutions to provide simplified, high-quality, and transparent healthcare for their employees and families at a reasonable cost could be a longer-term health care disruptor but it may a little premature to jump to conclusions.

TODAY'S FREE FLY STORIES

RYTM

Rhythm Pharmaceuticals

$26.45

0.21 (0.80%)

22:08
06/20/18
06/20
22:08
06/20/18
22:08
Syndicate
Rhythm Pharmaceuticals 5.732M share Secondary priced at $26.42 »

Morgan Stanley,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 21

    Jun

AMCX

AMC Networks

$67.45

1.28 (1.93%)

22:06
06/20/18
06/20
22:06
06/20/18
22:06
Downgrade
AMC Networks rating change at Bernstein »

AMC Networks downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

APTX

Aptinyx

$0.00

(0.00%)

20:45
06/20/18
06/20
20:45
06/20/18
20:45
Syndicate
Aptinyx 6.4M share IPO priced at $16.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

AVRO

AvroBio

$0.00

(0.00%)

20:44
06/20/18
06/20
20:44
06/20/18
20:44
Syndicate
AvroBio 5.25M share IPO priced at $19.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

TV

Televisa

$18.25

0.51 (2.87%)

20:43
06/20/18
06/20
20:43
06/20/18
20:43
Downgrade
Televisa rating change at Scotiabank »

Televisa downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

Cemex

$6.33

0.115 (1.85%)

20:42
06/20/18
06/20
20:42
06/20/18
20:42
Upgrade
Cemex rating change at Santander »

Cemex upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PH

Parker-Hannifin

$164.49

0.74 (0.45%)

20:41
06/20/18
06/20
20:41
06/20/18
20:41
Downgrade
Parker-Hannifin rating change at Wells Fargo »

Parker-Hannifin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMT

Kennametal

$37.44

1.11 (3.06%)

20:41
06/20/18
06/20
20:41
06/20/18
20:41
Downgrade
Kennametal rating change at Wells Fargo »

Kennametal downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNT

Syntel

$34.07

0.65 (1.94%)

20:40
06/20/18
06/20
20:40
06/20/18
20:40
Downgrade
Syntel rating change at Wells Fargo »

Syntel downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MGTA

Magenta Therapeutics

$0.00

(0.00%)

20:28
06/20/18
06/20
20:28
06/20/18
20:28
Syndicate
Magenta Therapeutics 6.667M share IPO priced at $15.00 »

The deal priced in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

XERS

Xeris Pharmaceuticals

$0.00

(0.00%)

20:26
06/20/18
06/20
20:26
06/20/18
20:26
Syndicate
Xeris Pharmaceuticals 5.7M share IPO priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

KR

Kroger

$26.21

0.21 (0.81%)

, DRI

Darden

$93.27

-1.34 (-1.42%)

20:25
06/20/18
06/20
20:25
06/20/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

KR

Kroger

$26.21

0.21 (0.81%)

DRI

Darden

$93.27

-1.34 (-1.42%)

CMC

Commercial Metals

$23.67

0.44 (1.89%)

PDCO

Patterson Companies

$22.54

0.07 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 21

    Jun

  • 21

    Jun

  • 28

    Jun

  • 10

    Jul

IIIV

i3 Verticals

$0.00

(0.00%)

20:24
06/20/18
06/20
20:24
06/20/18
20:24
Syndicate
i3 Verticals 6.65M share IPO priced at $13.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

KZR

Kezar Life Sciences

$0.00

(0.00%)

20:23
06/20/18
06/20
20:23
06/20/18
20:23
Syndicate
Kezar Life Sciences 5M share IPO priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

LPL

LG Display

$8.91

-0.015 (-0.17%)

20:08
06/20/18
06/20
20:08
06/20/18
20:08
Periodicals
LG Display discussing early retirement options for workers, Bloomberg reports »

LG Display is considering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGO

Eldorado Gold

$1.13

-0.02 (-1.75%)

20:05
06/20/18
06/20
20:05
06/20/18
20:05
Hot Stocks
Eldorado Gold provides update on Lamaque exploration and development »

Eldorado Gold is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, RSX

Market Vectors Russia ETF

$20.52

0.22 (1.08%)

19:43
06/20/18
06/20
19:43
06/20/18
19:43
Periodicals
Trump planning to meet with Russia's Putin in Europe next month, Bloomberg says »

Donald Trump and…

SPX

S&P 500

$0.00

(0.00%)

RSX

Market Vectors Russia ETF

$20.52

0.22 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEO

CNOOC

$163.48

2.345 (1.46%)

19:29
06/20/18
06/20
19:29
06/20/18
19:29
Periodicals
CNOOC to proceed with expansion in Canada's oil sands, Reuters reports »

CNOOC's Nexen Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$134.34

-1.815 (-1.33%)

19:14
06/20/18
06/20
19:14
06/20/18
19:14
Periodicals
Toyota to reduce marketing costs to fund new research, Reuters reports »

Toyota Motors has started…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$202.08

4.62 (2.34%)

, GOOG

Alphabet

$1,169.38

1.52 (0.13%)

19:06
06/20/18
06/20
19:06
06/20/18
19:06
Periodicals
FTC chair wants to explore market power of big internet firms, Reuters says »

New U.S. Federal Trade…

FB

Facebook

$202.08

4.62 (2.34%)

GOOG

Alphabet

$1,169.38

1.52 (0.13%)

GOOGL

Alphabet Class A

$1,183.83

5.54 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

RYAAY

Ryanair

$117.11

3.54 (3.12%)

19:01
06/20/18
06/20
19:01
06/20/18
19:01
Periodicals
IAG, Ryanair preparing EU legal challenge over air traffic strikes, FT reports »

IAG and Ryanair are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNED

Barnes & Noble Education

$6.78

0.3 (4.63%)

, MU

Micron

$58.97

-0.26 (-0.44%)

19:00
06/20/18
06/20
19:00
06/20/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Barnes…

BNED

Barnes & Noble Education

$6.78

0.3 (4.63%)

MU

Micron

$58.97

-0.26 (-0.44%)

SCS

Steelcase

$15.55

0.2 (1.30%)

LITE

Lumentum

$56.45

0.8 (1.44%)

HPQ

HP Inc.

$23.31

-0.215 (-0.91%)

THO

Thor Industries

$104.81

6.5 (6.61%)

GLW

Corning

$28.40

0.015 (0.05%)

AOBC

American Outdoor Brands

$13.22

0.13 (0.99%)

LMNR

Limoneira

$26.65

0.63 (2.42%)

VERI

Veritone

$21.52

-0.64 (-2.89%)

TRUP

Trupanion

$41.07

0.8 (1.99%)

ARRS

Arris

$25.51

0.015 (0.06%)

WIX

Wix.com

$107.70

1.15 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 21

    Jun

  • 22

    Jun

  • 09

    Jul

  • 10

    Jul

  • 11

    Jul

  • 12

    Jul

  • 21

    Jun

  • 21

    Jun

  • 21

    Jun

DIS

Disney

$107.28

1.08 (1.02%)

18:55
06/20/18
06/20
18:55
06/20/18
18:55
Periodicals
Disney puts future 'Star Wars' spinoffs on hold, Collider reports »

Disney's Lucasfilm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

SPY

SPDR S&P 500 ETF Trust

$276.00

0.52 (0.19%)

, SPX

S&P 500

$0.00

(0.00%)

18:54
06/20/18
06/20
18:54
06/20/18
18:54
Periodicals
Trump sees U.S. quarterly GDP going much higher, Bloomberg reports »

Says the head of U.S.…

SPY

SPDR S&P 500 ETF Trust

$276.00

0.52 (0.19%)

SPX

S&P 500

$0.00

(0.00%)

X

U.S. Steel

$35.72

0.56 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,169.38

1.52 (0.13%)

, GOOGL

Alphabet Class A

$1,183.83

5.54 (0.47%)

18:51
06/20/18
06/20
18:51
06/20/18
18:51
Hot Stocks
Senators Cotton, Rubio urge Google to reconsider work with Huawei »

Senator Tom Cotton along…

GOOG

Alphabet

$1,169.38

1.52 (0.13%)

GOOGL

Alphabet Class A

$1,183.83

5.54 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.